Cash & Short-Term Investments

$7.85B

Quarterly · Period ending: Jun 30, 2026 · USD

Latest reported$7.85Bperiod endingJun 30, 2026

VRTX Quarterly Cash & Short-Term Investments ($4.40M → $7.85B)

Quarterly Cash & Short-Term Investments

High-resolution chart · PNG

VRTX cash & short-term investments history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Vertex Pharmaceuticals Cash & Short-Term Investments — Quarterly (USD)
Period ending	Cash & Short-Term Investments (USD)
Jun 30, 2001	320,028,000
Mar 31, 2001	323,336,000
Dec 31, 2000	459,921,000
Sep 30, 2000	713,347,000
Jun 30, 2000	378,385,000
Mar 31, 2000	347,248,000
Dec 31, 1999	187,802,000
Sep 30, 1999	188,100,000
Jun 30, 1999	11,200,000
Mar 31, 1999	19,800,000
Dec 31, 1998	24,200,000
Sep 30, 1998	49,700,000
Jun 30, 1998	36,300,000
Mar 31, 1998	58,400,000
Dec 31, 1997	71,500,000
Sep 30, 1997	177,200,000
Jun 30, 1997	188,600,000
Mar 31, 1997	84,900,000
Dec 31, 1996	34,900,000
Sep 30, 1996	39,100,000
Jun 30, 1996	9,300,000
Mar 31, 1996	20,200,000
Dec 31, 1995	28,400,000
Sep 30, 1995	39,400,000
Jun 30, 1995	44,100,000
Mar 31, 1995	51,400,000
Dec 31, 1994	71,600,000
Sep 30, 1994	48,500,000
Jun 30, 1994	21,300,000
Mar 31, 1994	54,300,000
Dec 31, 1993	28,600,000
Sep 30, 1993	15,000,000
Jun 30, 1993	6,500,000
Mar 31, 1993	15,000,000
Dec 31, 1992	11,600,000
Sep 30, 1992	22,700,000
Jun 30, 1992	16,300,000
Mar 31, 1992	24,800,000
Dec 31, 1991	27,600,000
Sep 30, 1991	7,400,000
Jun 30, 1991	2,300,000
Dec 31, 1990	4,400,000